AstraZeneca cancels UK plant after subsidies cut
BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million (S$756.9 ...
BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million (S$756.9 ...
BEIJING’S mayor called on AstraZeneca to expand its research and development investment in the Chinese capital, signalling that a probe ...
DRUGMAKER AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on Tuesday ...
It was not immediately clear whether the executive Leon Wang was in the custody of the Chinese governmentAstraZeneca’s China president ...
Hong Kong-based CSPC will also get an upfront payment of US$100 million as part of the dealAstraZeneca said on Monday ...
Anglo-Swedish drugmaker AstraZeneca raised its full year sales and profit forecast on Thursday (Jul 25) after beating analyst expectations for ...
ASTRAZENECA aims to grow revenue by about 75 per cent to US$80 billion by 2030, it said on Tuesday (May ...
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that ...
ASTRAZENECA is planning to build a US$1.5 billion facility in Singapore to manufacture antibody drug conjugates (ADCs), or treatments that ...
London’s benchmark FTSE 100 stock index opened at a record high on Wednesday led by AstraZeneca, after the drugmaker initiated ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.